Gemcitabine plus Cisplatin versus Gemcitabine plus Carboplatin in Stage IIIb and IV Non Small Lung Cancer: A phase III Randomized Trial

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F03%3A00009442" target="_blank" >RIV/00216224:14110/03:00009442 - isvavai.cz</a>

Alternative codes found

RIV/65269705:_____/03:00007892

Result on the web

—

DOI - Digital Object Identifier

—

Result language

angličtina

Original language name

Gemcitabine plus Cisplatin versus Gemcitabine plus Carboplatin in Stage IIIb and IV Non Small Lung Cancer: A phase III Randomized Trial

Original language description

The ranomized, muticenter, phase III trial was conducted to compare the tolerability of gemcitabine plus cisplatine (GP) vs. gemcitabine plus carpolatin (GC). The enroled patients in GC and GP arm were balanced for demographic and disease characteristics. Both GP and GC are ffective options, the GC arm offering the advantage to pts unable to receive cisplatin.

Czech name

—

Czech description

—

Type

J_x - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

CEP classification

FC - Pneumology

OECD FORD branch

—

Project

—

Continuities

Z - Vyzkumny zamer (s odkazem do CEZ)

Publication year

2003

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Lung Cancer

ISSN

0169-5002

e-ISSN

—

Volume of the periodical

41

Issue of the periodical within the volume

sup 2

Country of publishing house

CZ - CZECH REPUBLIC

Number of pages

1

Pages from-to

65

UT code for WoS article

—

EID of the result in the Scopus database

—